Trials / Recruiting
RecruitingNCT07098650
Haemdall: Developing a Quantitative MRI Biomarker of Infratentorial Superficial Siderosis of the Central Nervous System
Haemdall: Developing a Quantitative MRI Biomarker of Classical (Infratentorial) Superficial Siderosis of the Central Nervous System
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Perspectum · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Haemdall: Using Medical Imaging to measure Brain Iron in Superficial Siderosis. This study is looking at a new way of using MRI scans to potentially measure the amount of iron on the surface of the brain. Iron build up in the brain is linked to how superficial siderosis develops. The study will also aim to see if there is a connection between the amount of iron in the brain and common superficial siderosis symptoms. Clinical tests will be used to measure symptoms including tests to measure your hearing, walking \& balance and participants' ability to remember, think and understand.
Conditions
Timeline
- Start date
- 2025-08-14
- Primary completion
- 2026-10-31
- Completion
- 2026-12-31
- First posted
- 2025-08-01
- Last updated
- 2025-08-20
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT07098650. Inclusion in this directory is not an endorsement.